Portfolio Thuja Capital Healthcare Fund II
Eindhoven based company developing a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.
Radboud UMC (Nijmegen) spin-off CardiacBooster develops a minimally invasive cardiac assist device indicated to temporarily support the heart through episodes of acute distress such as cariogenic shock or acute heart failure.
Nijmegen based Radboudumc spin-off Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.
Wageningen based company active in the field of medical nutrition and functional foods. Currently develops a food ingredient with immune system enhancing properties to help combat infections.
Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.